# FDA Inspection 1195661 - Kwabena (NMI) Ayesu, M.D. - January 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/kwabena-nmi-ayesu-md/0ee2832f-03d0-4794-9d18-f1b97b7d0537
Source feed: FDA_Inspections

> FDA Inspection 1195661 for Kwabena (NMI) Ayesu, M.D. on January 27, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195661
- Company Name: Kwabena (NMI) Ayesu, M.D.
- Inspection Date: 2023-01-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1139836 - 2021-04-02](https://www.keypedia.com/records/fda_inspections/kwabena-nmi-ayesu-md/44e1061c-49f0-427b-99d4-7efb4b1b4ce0)
- [FDA Inspection 1099885 - 2019-07-31](https://www.keypedia.com/records/fda_inspections/kwabena-nmi-ayesu-md/e974a181-ac87-43ab-a538-dfe76fa288e7)

Company: https://www.keypedia.com/companies/kwabena-nmi-ayesu-md/9e5eea3e-0997-4f23-a9f3-935bec5b4c97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c